Bioactive natural products have evolved to inhibit specific cellular targets and have served as lead molecules for health and agricultural applications for the past century 1-3 . The post-genomics era has brought a renaissance in the discovery of natural products using synthetic-biology tools 4-6 . However, compared to traditional bioactivity-guided approaches, genome mining of natural products with specific and potent biological activities remains challenging 4 . Here we present the discovery and validation of a potent herbicide that targets a critical metabolic enzyme that is required for plant survival. Our approach is based on the co-clustering of a selfresistance gene in the natural-product biosynthesis gene cluster 7-9 , which provides insight into the potential biological activity of the encoded compound. We targeted dihydroxy-acid dehydratase in the branched-chain amino acid biosynthetic pathway in plants; the last step in this pathway is often targeted for herbicide development 10 . We show that the fungal sesquiterpenoid aspterric acid, which was discovered using the method described above, is a sub-micromolar inhibitor of dihydroxy-acid dehydratase that is effective as a herbicide in spray applications. The self-resistance gene astD was validated to be insensitive to aspterric acid and was deployed as a transgene in the establishment of plants that are resistant to aspterric acid. This herbicide-resistance gene combination complements the urgent ongoing efforts to overcome weed resistance 11 . Our discovery demonstrates the potential of using a resistance-gene-directed approach in the discovery of bioactive natural products.
natural products with novel biological activities 4, 6 . Although no naturalproduct inhibitors of DHAD are known to date, we reason that a fungal natural product with this property might exist, given the indispensable role of BCAA biosynthesis in plants 10 .
To identify natural-product biosynthetic gene clusters that may encode a DHAD inhibitor, we hypothesized that such a cluster must contain an additional copy of DHAD that is insensitive to the inhibitor, thereby providing the required self-resistance for the producing organism to survive. Genes encoding a self-resistance enzyme are frequently found in microbial natural-product gene clusters, as highlighted by the presence of an insensitive copy of HMG-CoA reductase (HMGR) and inosine monophosphate dehydrogenase (IMPDH) in the gene clusters of lovastatin (that targets HMGR) and mycophenolic acid (that targets IMPDH), respectively 19, 20 (Extended Data Fig. 1c ). This phenomenon has been used to predict molecular targets of natural products, as well as to identify gene clusters of natural products of known activities 5,7,9 . To identify possible self-resistance enzymes, we scanned sequenced fungal genomes to search for co-localization of genes encoding DHAD with core biosynthetic enzymes, such as terpene cyclases and polyketide synthases among others 21, 22 . We identified a well-conserved set of four genes across multiple fungal genomes ( Fig. 1b) , including the common soil fungus Aspergillus terreus that is best known for producing lovastatin. The conserved gene clusters include genes that encode a sesquiterpene cyclase homologue (astA), two cytochrome P450 genes (astB and astC) and a homologue of DHAD (astD). Genes outside of this cluster are not conserved across the identified genomes and are hence unlikely to be involved in the biosynthesis of natural products. AstD is the second copy of DHAD encoded in the genome, and is approximately 70% similar to the housekeeping copy that is well-conserved across fungi ( Supplementary Fig. 2 ). Therefore, AstD is potentially a self-resistance enzyme that confers resistance to the encoded natural product. As with a majority of biosynthetic gene clusters in sequenced fungal genomes, the ast cluster has not been associated with the production of a known natural product 4 .
To identify the natural product encoded by the ast cluster, we heterologously expressed astA, astB and astC genes in the host Saccharomyces cerevisiae RC01 23 . New compounds that emerged were purified and their structures were elucidated using NMR spectroscopy ( Supplementary Fig. 3 , Supplementary Table 5 ). RC01 cells expressing only astA produced a new sesquiterpene (1) , which was confirmed to be (−)-daucane ( Supplementary Fig. 4 ). RC01 cells expressing both astA and astB led to the biosynthesis of a new product that was determined structurally to be the α-epoxy carboxylate (2) (Fig. 1c ). When astA, astB and astC were expressed together, a new compound (3) became the dominant product (approximately 20 mg l −1 ). Full structural determination revealed 3 to be the tricyclic aspterric acid, which is a previously isolated compound 24 (Fig. 1c) . The biosynthetic pathway for aspterric Letter reSeArCH acid is therefore concise: after cyclization of farnesyl diphosphate by AstA to create the carbon skeleton in 1, AstB catalyses oxidation of 1 to yield the epoxide 2. Further oxidation by AstC at carbon 15 yields an alcohol, which can undergo intramolecular epoxide opening to create aspterric acid ( Fig. 1d ).
Upon its initial discovery, aspterric acid was shown to have inhibitory activity towards Arabidopsis thaliana, however, the mode of action was not known 25 . Our resistance-gene-directed approach led to rediscovery of this compound with DHAD as a potential target. We first confirmed that aspterric acid is able to potently inhibit A. thaliana growth in an agar-based assay ( Fig. 2a, Supplementary Fig. 5 ). Aspterric acid was also an effective inhibitor of root development and plant growth when applied to a representative monocot (Zea mays) and dicot (Solanum lycopersicum) (Fig. 2b) . To test whether aspterric acid indeed targets DHAD, we expressed and purified housekeeping DHAD from both A. terreus (XP_001208445.1, AteDHAD) and A. thaliana (AT3G23940, AthDHAD), as well as the putative self-resistance enzyme AstD ( Supplementary Fig. 6 ). Both housekeeping DHAD enzymes converted dihydroxyisovalerate to ketoisovalerate (AthDHAD: k cat = 1.2 s −1 , K M = 5.7 mM) as expected. The enzyme activities, however, were inhibited in the presence of aspterric acid (Extended Data Fig. 2 ). The half-maximal inhibitory concentration (IC 50 ) values of aspterric acid towards AteDHAD and AthDHAD were 0.31 μM and 0.50 μM, respectively, at an enzyme concentration of 0.50 μM (Extended Data Fig. 3 ). Aspterric acid was further determined to be a competitive inhibitor of AthDHAD with a K i = 0.30 μM (Extended Data Fig. 3 ). Aspterric acid displayed no significant cytotoxicity towards human cell lines up to 500 μM concentration, consistent with the lack of DHAD in mammalian cells ( Supplementary Fig. 7) .
AstD catalyses the identical β-dehydration reaction as DHAD, albeit with a significantly slower turnover rate (k cat = 0.03 s −1 , K M = 5.4 mM).
However, the enzyme was not inhibited by aspterric acid, even at the solubility limit of 8 mM (Extended Data Fig. 3 ). To determine if AstD can confer resistance to aspterric acid-sensitive strains, we developed a yeast-based assay. The genome copy of DHAD encoded by ILV3 was first deleted from the S. cerevisiae strain DHY ΔURA3, which resulted in an auxotroph that requires exogenous addition of Ile, Leu and Val to grow. We introduced either the gene encoding AteDHAD or astD episomally into the ILV3 knockout strain and found that both genes enabled the cells to grow in the absence of the three BCAAs (Extended Data Fig. 4 ). However, yeast cells expressing AteDHAD were approximately 100 times more sensitive to aspterric acid (IC 50 of 2 μM) compared to yeast expressing AstD (IC 50 of 200 μM) ( Fig. 2c ). Collectively, the biochemical and genetic assays validated that aspterric acid is, to our knowledge, the first natural-product inhibitor of fungal and plant DHAD, and that AstD serves as the self-resistance enzyme in the ast biosynthetic gene cluster.
The (R)-α-hydroxyacid and (R)-configured β-ether oxygen moieties in aspterric acid mimic the (2R, 3R)-dihydroxy groups present in natural substrates such as dihydroxyisovalerate. The β-ether oxygen in aspterric acid is in a position to coordinate to the 2Fe-2S cluster that is a required cofactor in both fungal and plant DHAD 16, 17 . To understand the potential mechanism of action of aspterric acid, we determined the crystal structure (2.11 Å) of AthDHAD in complex with the 2Fe-2S cluster (holo-AthDHAD) ( Fig. 2d , Extended Data Fig. 5 , Extended Data Table 1 ). We identified a binding chamber at the homodimer interface, similar to that found in the holo bacterial l-arabinonate dehydratase 26 (Fig. 2d ). The interior of the chamber is positively charged (2Fe-2S and Mg 2+ ) whereas the entrance is lined with hydrophobic residues. The modelled binding mode of α,β-dihydroxyisovalerate and aspterric acid predicted by computational docking are shown in Fig. 2e . The pocket is sufficiently spacious to accommodate the bulkier aspterric , which are also conserved among several fungal species. astA has sequence homology to sesquiterpene cyclase; astB and astC are predicted to be P450 monooxygenases; astD is predicted to encode a DHAD and is proposed to confer self-resistance in the presence of the natural product produced in the cluster. c, High-performance liquid chromatography-mass spectrometry (HPLC-MS) traces of metabolites produced from S. cerevisiae RC01 expressing the different ast genes under the P ADH2 promoter control. Control, S. cerevisiae without expression plasmids; S. cerevisiae transformed with plasmids expressing astA and astB, which produces 2; and S. cerevisiae transformed with plasmids expressing astA-C, which produces aspterric acid at a titre of 20 mg l −1 . The experiments were repeated independently with similar results three times. EIC, extracted ion chromatogram. d, Proposed biosynthetic pathway of aspterric acid. AstA cyclizes farnesyl diphosphate (FPP) into 1 and the P450 enzymes AstB and AstC then sequentially transform 1 into 2 and aspterric acid (3, AA), respectively. MM, molecular mass.
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acid, and provide stronger hydrophobic interactions than the native substrate with a 5.3 ± 0.3 kcal mol −1 gain in binding energy ( Fig. 2e ).
On the basis of the holo-AthDHAD structure, we constructed a homology model of AstD to determine the potential mechanism of resistance (Extended Data Figs. 5, 6). Comparison of AthDHAD and the modelled AstD structures shows that although most of the residues in the catalytic chamber are conserved, the hydrophobic region at the entrance to the reactive chamber in AstD is more constricted as a result of two amino acid substitutions (V496L and I177L). Narrowing of the entrance could therefore sterically exclude the bulkier aspterric acid from binding in the active site, whereas the smaller, natural substrates are still able to enter the chamber.
To explore the potential of aspterric acid as an herbicide, we performed spray treatment of A. thaliana with aspterric acid. We added aspterric acid into a commercial glufosinate formulation known as Finale at a final concentration of 250 μM 27, 28 . We then sprayed aspterric acid solution onto glufosinate-resistant A. thaliana. Finale alone had no observable inhibitory effects on plant growth, but adding aspterric acid severely inhibited plant growth (Extended Data Fig. 7 ). In addition, A. thaliana plants treated with aspterric acid before flowering failed to form normal pollen, which has also been observed previously 25 . We found that the pistil of treated plants could still be successfully pollinated using healthy pollen from the untreated A. thaliana, indicating that aspterric acid preferentially affects pollen but not egg formation (Extended Data Figs. 8, 9) . This effect was also observed with a lower concentration of aspterric acid (100 μM). Thus, in addition to its herbicidal properties, aspterric acid could potentially be used as a chemical hybridization agent for hybrid seed production 29 .
We next investigated whether plants expressing astD are resistant to aspterric acid. This was motivated by the successful combination of glyphosate and genetically modified crops that are selectively resistant to glyphosate (Roundup Ready) 30 . The A. terreus astD gene was codon optimized and the N terminus was fused to a chloroplast localization signal derived from AthDHAD. Wild-type or astD transgene-expressing 
A. thaliana was then grown on medium that contained 100 μM aspterric acid. In the presence of aspterric acid, the growth of wild-type plants was strongly inhibited, and arrested at the cotyledon stage ( Fig. 3a) . By contrast, the growth of astD transgenic plants was relatively unaffected by aspterric acid, as indicated by the normally expanded rosette leaves, elongated roots and whole-plant fresh weight ( Fig. 3a, b ). The expression of AstD was verified by western blot ( Supplementary Fig. 8 ). A spray assay was also performed using T2 astD transgenic A. thaliana plants, which showed no observable growth defects under such treatment ( Fig. 3c ). By contrast, the control plants carrying the empty vector showed a strong growth inhibitory phenotype when treated with aspterric acid (Fig. 3c ). Quantitative measurements of plant height showed that AstD effectively confers aspterric acid resistance to A. thaliana (Fig. 3d ).
In summary, resistance-gene-directed discovery of natural products in the fungus A. terreus led to the discovery of a natural herbicide aspterric acid and the determination of its mode of action. In addition, introducing astD as a transgene or editing the sequence of the plant DHAD endogenous gene could be used to create aspterric acid-resistant crops. We suggest that aspterric acid is a promising lead for development as a broad spectrum commercial herbicide.
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MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Materials. Biological reagents, chemicals, media and enzymes were purchased from standard commercial sources unless stated. The plant, fungal, yeast and bacterial strains, plasmids and primers used in this study are summarized in Supplementary Tables 3, 4 and 5. DNA and RNA manipulations were carried out using Zymo ZR Fungal/Bacterial DNA Microprep kit and Invitrogen Ribopure kit respectively. DNA sequencing was performed at Laragen. The primers and codon-optimized gblocks were synthesized by IDT. Expression of ast genes in Aspergillus nidulans for cDNA isolation. Plasmids pYTU, pYTP, pYTR were digested with PacI and SwaI and used as vectors to insert genes 31 . A gpda promoter was generated by PCR amplification using primers Gpda-pYTU-F and Gpda-R with pYTR serving as template. Genes to be expressed were amplified using PCR with the genomic DNA of A. terreus NIH2624 as a template. A 4.5-kb fragment obtained using primers AstD-pYTU-recomb-F and AstA-pYTU-recomb-R was cloned into pYTU together with a gpda promoter by yeast homologous recombination to obtain pAstD+AstA-pYTU. Yeast transformation was performed using Frozen-EZ Yeast Transformation II Kit (Zymo Research). A 2.4-kb fragment obtained using primers AstB-pYTR-recomb-F and AstB-pYTRrecomb-R was cloned into pYTR by yeast homologous recombination to obtain pAstB-pYTR. Similarly, a 2.3-kb fragment obtained using primers AstC-pYTPrecomb-F and AstC-pYTP-recomb-R was cloned into pYTP by yeast homologous recombination to obtain pAstC-pYTP.
All three plasmids (pAstD+AstA-pYTU, pAstB-pYTR and pAstC-pYTP) were transformed into A. nidulans according to standard protocols to result in the A. nidulans strain TY01 31 . TY01 was cultured in liquid CD-ST medium (20 g l −1 starch, 20 g l −1 peptone, 50 ml l −1 nitrate salts and 1 ml l −1 trace elements) at 28 °C for 3 days. Total RNA of TY01 was extracted with the Invitrogen Ribopure kit, and total cDNA of TY01 was obtained using the SuperScript III reverse transcriptase kit (Thermo Fisher Scientific). The cDNA fragment of astA was PCR amplified using primers AstA-xw55-recomb-F and AstA-xw55-recomb-R. The cDNA fragment of astB was PCR amplified using primers AstB-xw06-recomb-F and AstB-xw06-recomb-R. The cDNA fragment of astC was PCR amplified using primers AstC-xw02-recomb-F and AstC-xw02-recomb-R. The cDNA fragment of astD was PCR amplified using primers AstD-pXP318-F and AstD-pXP318-R. All the introns were confirmed to be correctly removed by sequencing. Construction of S. cerevisiae strains. Plasmid pXW55 (URA3 marker) digested with NdeI and PmeI was used to introduce the astA gene 23 into S. cerevisiae RC01. A 1.3-kb fragment containing astA obtained from PCR using primers AstA-xw55recomb-F and AstA-xw55-recomb-R was cloned into pXW55 using yeast homologous recombination to produce pAstA-xw55. The plasmid pAstA-xw55 was then transformed into S. cerevisiae RC01 to generate strain TY02 23 .
Plasmid pXW06 (TRP1 marker) digested with NdeI and PmeI was used to introduce the astB gene 23 S. cerevisiae RC01. A 1.6-kb fragment containing astB obtained from PCR using primers AstB-xw06-recomb-F and AstB-xw06recomb-R were cloned into pXW06 using yeast homologous recombination to produce pAstB-xw06. The plasmid pAstB-xw06 was then transformed into TY02 to generate strain TY03.
Plasmid pXW06 (LEU2 marker) digested with NdeI and PmeI was used to introduce the astC gene 23 S. cerevisiae RC01. A 1.6-kb fragment containing astC obtained from PCR using primers AstC-xw02-recomb-F and AstC-xw02recomb-R were cloned into pXW02 using yeast homologous recombination to produce pAstC-xw02. The plasmid pAstC-xw02 was then transformed into TY03 to generate strain TY04.
The URA3 gene was inserted into the ILV3 locus of S. cerevisiae DHY ΔURA3 strain to generate UB01. A 879-bp homologous-recombination donor fragment with 35-40 bp homologous regions flanking the ILV3 ORF was amplified using primers ILV3p-URA3-F and ILV3t-URA3-R using yeast gDNA as a template. The PCR product was gel purified and transformed into S. cerevisiae DHY ΔURA3, and selected on uracil dropout medium to give UB01. The resulting strain was subjected to verification using colony PCR with primers ILV3KO-ck-F and ILV3KOck-R and the amplified fragment was confirmed with sequencing.
The URA3 gene inserted into the ILV3 locus of S. cerevisiae DHY ΔURA3 was deleted from UB01 using homologous recombination to generate UB02. A 150bp homologous-recombination donor fragment with 75-bp homologous regions flanking the ILV3 ORF was amplified using primers ILV3KO-F and ILV3KO-R, gel purified, transformed into UB01, and counter-selected on 5-fluoroorotic acid (5-FoA)-containing medium to give UB02. The resulting strain was subjected to verification using colony PCR with primers ILV3KO-ck-F and ILV3KO-ck-R and the amplified fragment was confirmed with sequencing.
The empty plasmid pXP318 (URA3 marker) was transformed into UB02 to generate TY05 32 .
Plasmid pXP318 digested with SpeI and XhoI was used as vector to introduce the gene encoding AteDHAD 32 into the plasmid UB02. The cDNA of A. terreus NIH 2624 served as the template for PCR amplification. A 1.7-kb fragment obtained using primers AteDHAD-pXP318-F and AteDHAD-pXP318-R were cloned into pXP318 using yeast homologous recombination to produce AteDHAD-pXP318. Then, AteDHAD-pXP318 was transformed into UB02 to generate TY06. AteDHAD was driven by a constitutive TEF1 promoter.
Plasmid pXP318 digested with SpeI and XhoI was used as vector to introduce the astD gene 32 into the plasmid UB02. The cDNA isolated from TY01 served as the template for PCR amplification. A 1.8-kb fragment obtained using primers AstD-pXP318-F and AstD-pXP318-R were cloned into pXP318 using yeast homologous recombination to make AstD-pXP318. A Flag tag was also added to the N-terminal of AstD. AstD-pXP318 was then transformed into UB02 to generate TY07. AstD was driven by the constitutive TEF1 promoter. Fermentation and compound analyses and isolation. A seed culture of S. cerevisiae strain was grown in 40 ml of synthetic dropout medium for 2 days at 28 °C, 250 r.p.m. Fermentation of the yeast was carried out using YPD (yeast extract 10 g l −1 , peptone 20 g l −1 ) supplemented with 2% dextrose for 3 days at 28 °C, 250 r.p.m.
HPLC-MS analyses were performed using a Shimadzu 2020 EVLC-MS (Phenomenex Luna, 5μ, 2.0 × 100 mm, C-18 column) with positive and negative mode electrospray ionization. The elution method was a linear gradient of 5-95% (v/v) acetonitrile/water over 15 min, and then 95% (v/v) acetonitrile/water for 3 min with a flow rate of 0.3 ml min −1 . The HPLC buffers were supplemented with 0.05% formic acid (v/v). HPLC purifications were performed using a Shimadzu Prominence HPLC (Phenomenex Kinetex, 5μ, 10.0 × 250 mm, C-18 column). The elution method was a linear gradient of 65-100% (v/v) acetonitrile/water in 25 min, with a flow rate of 2.5 ml min −1 . Gas chromatography-mass spectrometry (GC-MS) analyses were performed using Agilent Technologies GC-MS 6890/5973 equipped with a DB-FFAP column. An inlet temperature of 240 °C and constant pressure of 4.2 psi were used. The oven temperature was initially set at 60 °C, then ramped up at 10 °C min −1 for 20 min and finally held at 240 °C for 5 min.
To isolate compound 1, the fermentation broth of TY02 was centrifuged (5,180g, 10 min), and the cell pellet was collected and soaked in acetone. The organic phase was dried over sodium sulfate, concentrated to oil form and subjected to silica column purification with hexane. To isolate compound 2, the fermentation broth of TY03 was centrifuged (5,180g, 10 min), and the supernatant was extracted three times with ethyl acetate. The organic phase was dried over sodium sulfate, concentrated to oil form, and then and subjected to HPLC purification. To isolate aspterric acid, the fermentation broth of TY04 was centrifuged (5,180g, 10 min), and supernatant was extracted three times with ethyl acetate. The organic phase was dried over sodium sulfate, concentrated to oil form, and subjected to HPLC purification. Structure determination of compounds. Compound 1, a colourless oil that readily dissolved in hexane and chloroform, had a molecular formula C 15 2. Both of the NMR and mass spectrometry spectra are identical to a known compound (+)-daucane, however, the optical rotation is opposite which led to the assignment of 1 to be (−)-daucane 33 .
Compound 2, a colourless oil that readily dissolved in ethyl acetate and chloroform, had a molecular formula C 15 24, 25 . Protein expression, purification and biochemical assay. To express and purify AthDHAD, primers AthDHAD-pET-F and AthDHAD-pET-R were used to amplify a 1.7-kb DNA fragment containing AthDHAD (AT3G23940). The PCR Letter reSeArCH product was cloned into pET28a using NheI and NotI restriction sites. The resulting plasmid AthDHAD-pET was transformed into E.coli BL21 (DE3) to give TY08. To express and purify AteDHAD (XP_001208445.1), primers AteDHAD-pET-F and AteDHAD-pET-R were used to amplify a 1.6-kb DNA fragment containing AteDHAD. The PCR product was cloned into pET28a using NdeI and NotI restriction sites. The resulting plasmid AteDHAD-pET was transformed into E. coli BL21 (DE3) to obtain TY09. To express and purify AstD (XP_001213593.1), primers AstD-pET-F and AstD-pET-R were used to amplify a 1.6-kb DNA fragment containing astD. The PCR product was cloned into pET28a using NdeI and NotI restriction sites. The resulting plasmid AstD-pET was transformed into E. coli BL21 (DE3) to obtain TY10. All DHADs with a fused 6 × His-tag with a molecular mass of ~62 kDa were expressed at 16 °C 220 rpm for 20 h after 100 μM isopropyl β-d-1-thiogalactopyranoside IPTG induction (IPTG was added when OD 600 nm = 0.8). Cells from a 1-l culture were then collected by centrifugation at 5,180g at 4 °C. Cell pellet was resuspended in 15 ml Buffer A10 (20 mM Tris-HCl pH 7.5, 50 mM NaCl, 8% glycerol, 10 mM imidazole). The cells were lysed by sonication, and the insoluble material was sedimented by centrifugation at 35,267g at 4 °C. The protein supernatant was then incubated with 3 ml Ni-NTA for 4 h with slow, constant rotation at 4 °C. Subsequently the Ni-NTA resin was washed with ten column volumes of Buffer A50 (Buffer A with 50 mM imidazole). For elution of the target protein, the Ni-NTA resin was incubated for 10 min with 6 ml Buffer A300 (Buffer A with 300 mM imidazole). The supernatant from the elution step was then analysed by SDS-PAGE together with the supernatants from the other purification steps. The elution fraction containing the recombinant protein was buffer exchanged into storage buffer (50 mM Tris-HCl pH 7.2, 50 mM NaCl, 10 mM MgCl 2 , 10% glycerol, 5 mM DTT, 5 mM GSH).
In vitro activity assays were carried out in 50 μl reaction mixture containing storage buffer, 10 mM (±)-sodium α,β-dihydroxyisovalerate hydrate (4) and 0.5 μM of purified DHAD enzyme. The reaction was initiated by adding the enzyme. After 0.5 h incubation at 30 °C, the reactions were stopped by adding an equal volume of ethanol. Approximately 0.1 volumes of 100 mM phenylhydrazine (PHH) was added to derivatize the product 3-methyl-2-oxo-butanoic acid (5) into 6 at room temperature for 30 min. 20 μl of the reaction mixture was used for the LC-MS analysis. The area of the HPLC peak with UV absorption at 350 nm were used to quantify the amount of 6. (Extended Data Fig. 2) .
The inhibition percentage of aspterric acid on DHADs was determined using in vitro biochemical assays and calculated with following equation: = − inhibition percentage 1 initial reaction rate with aspterric acid initial reaction rate without aspterric acid Growth inhibition assay of S. cerevisiae on plates or in the tubes. S. cerevisiae was grown in isoleucine, leucine and valine (ILV) dropout medium (20 g l −1 glucose, 0.67 g l −1 Difco Yeast Nitrogen Base without amino acids, 18 mg l −1 adenine, arginine 76 mg l −1 , asparagine 76 mg l −1 , aspartic acid 76 mg l −1 , glutamic acid 76 mg l −1 , histidine 76 mg l −1 , lysine 76 mg l −1 , methionine 76 mg l −1 , phenylalanine 76 mg l −1 , serine 76 mg l −1 , threonine 76 mg l −1 , tryptophan 76 mg l −1 , tyrosine 76 mg l −1 ) to test growth inhibition of aspterric acid on S. cerevisiae, cells were incubated at 28 °C until OD 600 nm of the control strain without aspterric acid treatment reached about 0.8. The ratio of yeast OD 600 nm in medium with aspterric acid treatment to yeast OD 600 in medium without aspterric acid was calculated as the percentage of growth inhibition. The inhibition curve was plotted as the percentage of inhibition versus aspterric acid concentrations. To further prove aspterric acid affects BCAA biosynthesis, isoleucine, leucine and valine were also complemented to the medium with or without treatment with aspterric acid. The growth curves of TY05, TY06 and TY07 were also plotted in Extended Data Fig. 4 . The OD 600 nm was recorded for every 20 min over a total of 50 h. The growth inhibition percentage of aspterric acid on S. cerevisiae strain is calculated by dividing the cell density (OD 600 nm ) of the aspterric acid-treated strain to the corresponding untreated strains when OD 600 nm reaches approximately 0.8 using the following equation: The control plants were treated with solvent containing ethanol only. A. thaliana that are resistant to glufosinate (containing the bar gene) were grown under long day condition (16/8 h light/dark) using cool-white fluorescence bulbs as the light resource at 23 °C. Spraying treatments began upon seed germination and were repeated once every two days with approximately 0.4 ml aspterric acid solution each time per pot. Structure determination of holo-AthDHAD. The gene encoding AthDHAD (residues 35-608) was cloned into pET21a derivative vector pSJ2 with an eight histidine (8 × His) tag and a TEV protease cleavage site at the N-terminus. The forward primer DHAD-F and the reverse primer DHAD-R were used for cloning. The double mutant K559A/K560A for efficient crystallization was designed using the surface entropy reduction prediction (SERp) server 34 . Mutations were generated by PCR using the forward primer K559AK560A-F and reverse primer K559AK560A-R. All constructed plasmids were verified by DNA sequencing.
AthDHAD purified under aerobic conditions was found to contain no ironsulfur cluster (apo form). Hence we performed [2Fe-2S] cluster reconstitution under the atmosphere of nitrogen in an anaerobic box. The protein was incubated with FeCl 3 at the ratio of 1:10 for 1 h on ice and then 10 equivalents of Na 2 S per protein was added drop-wise every 30 min for 3 h. The reaction mixture was then incubated overnight. Excess FeCl 3 and Na 2 S were removed using a SephadexTM G-25 Fine column (GE Healthcare) 26 .
The reconstituted holo-AthDHAD was crystallized in an anaerobic box. The proteins (at 10 mg ml −1 ) were mixed in a 1:1 ratio with the reservoir solution in a 2-μl volume and equilibrated against 50 μl reservoir solution, using the sitting-drop vapour diffusion method at 16 °C. Crystals for diffraction were observed in 0.1 M sodium acetate pH 5.0, 1.5 M ammonium sulfate after 5 days.
All crystals were flash-cooled in liquid nitrogen after cryo-protection with a solution containing 25% glycerol, 1.5 M ammonium sulfate, 0.1 M sodium acetate pH 5.0. The data were collected at 100 K at the Beam Line 19U1 in the Shanghai Synchrotron Radiation Facility (SSRF). Diffraction data of holo-AthDHAD were collected at the wavelength of 0.97774 Å. The best crystals diffracted to a resolution of 2.11 Å. The Ramachandran plot favoured (%), allowed (%) and outlier (%) are 98.05, 1.60, and 0.36, respectively. All datasets were indexed, integrated, and scaled using the HKL3000 package 35 . The crystals belonged to space group P4 2 2 1 2. The statistics of the data collection are summarized in Extended Data Table 1 .
The holo-AthDHAD structure was solved using the molecular replacement method Phaser embedded in the CCP4i suite and the l-arabinonate dehydratase crystal structure (RCSB Protein Data Bank (PDB) ID: 5J83) as the search model. All the side chains were removed during the molecular replacement process 36, 37 . The resulting model was refined against the diffraction data using the REFMAC5 program of CCP4i 38 . On the basis of the improved electron density, the side chains of the holo-AthDHAD protein, iron-sulfur cluster, water molecule, acetate ion, sulfate ions, and magnesium ion were manually built using the program WinCoot 39 . The R work and R free values of the structure are 17.27% and 21.52%, respectively. The detailed refinement statistics are summarized in Extended Data Table 1 . The geometry of the model was validated by WinCoot. Structural factor and coordinate of holo-AthDHAD have been deposited in the Protein Data Bank (PDB ID: 5ZE4). Homology modelling of AstD and docking of substrate or aspterric acid into the active site of holo-AthDHAD. The structure of holo-AthDHAD was prepared using Schrodinger suite software under an OPLS3 force field 40 . Hydrogen atoms were added to reconstituted crystal structures according to the physiological pH (7.0) with the PROPKA tool in Protein Preparation tool in Maestro to optimize the hydrogen bond network 26, 41 . Constrained energy minimizations were conducted on the full-atomic models, with heavy atom coverage to 0.5 Å. The homology model was performed in Modeller 9.18 42 , using the crystal structure of holo-AthDHAD solved in this work as a template. Sequence alignment in Modeller indicated that AstD and AthDHAD shared 56.8% sequence identity and 75.0% sequence similarity (Extended Data Fig. 6 ). All the highly conserved residues and motifs were properly aligned. A total of 2,000 models were generated for each target in Modeller with the fully annealed protocol. The optimal models were chosen for docking studies according to DOPE (Discrete Optimized Protein Energy) score.
All ligand structures were built in Schrodinger Maestro software 26 . The LigPrep module in Schrodinger software was introduced for geometric optimization by using an OPLS3 force field 40 . The ionization states of ligands were calculated with Epik tool using Hammett and Taft methods in conjunction with ionization and tautomerization tools 43 . The docking of a ligand to the receptor was performed using Glide 44 . We included cofactors observed in the crystal structure during the docking. As both water and SO 4 2− occupied the catalytic site, they were excluded before docking. Cubic boxes centred on the ligand mass centre with a radius of 8 Å for all ligands defined the docking binding regions. Flexible ligand docking was executed for all structures. Ten poses per ligand out of 20,000 were included in the post-docking energy minimization. The best scored pose for the ligand was chosen as the initial structure for further study. The molecular mechanics energies combined with the generalized Born and surface area continuum solvation Letter reSeArCH (MM/GBSA) method was introduced to evaluate the ligand binding affinity on the basis of the best-scored docking pose in Schrodinger software. Figures were prepared in PyMOL and Inkscape 45, 46 . Both the native substrate α,β-dihydroxyisovalerate and aspterric acid were docked into the catalytic site of AthDHAD. The cross-section electrostatic surface map shows this unique catalytic pocket has a positively charged interior and a hydrophobic entrance, which binds to negatively charged 'head' and hydrophobic 'tail' of the substrate or aspterric acid, respectively. Thus the negatively charged 'head' can lead both of the substrate and aspterric acid into the catalytic chamber. The bulky hydrophobic tricyclic moiety of aspterric acid, however, provides stronger hydrophobic interactions to the entrance and blocks the entrance of the active site owing to the hydrophobic residues at the entrance (Fig. 2d) . By contrast, the smaller 'tail' of the native substrate provides fewer interactions to the entrance because the smaller size limits efficient hydrophobic contact to nearby residues. This implies that once aspterric acid binds to AthDHAD, it can prevent the substrate approaching the active site. We also introduced the MM/GBSA method, a widely used approach for relative binding energy calculation, to evaluate the relative binding affinity for both ligands 47 . The MM/GBSA calculations were done in Prime 48 (Schrödinger 2015 suite). The MM/GBSA energy was calculated using following equation, ΔG bind = E complex -E protein − E ligand . E denotes energy and includes terms such as protein−ligand van der Waals contacts, electrostatic interactions, ligand desolvation, and internal strain (ligand and protein) energies, using a VSGB2.0 implicit solvent model with the OPLS2005 force field. The solvent entropy is also included in the VSGB2.0 energy model, as it is for other generalized Born and Poison−Boltzmann continuum solvent models.
MM/GBSA calculation shows that the relative binding energy for aspterric acid and α,β-dihydroxyisovalerate is −18.6 ± 0.3 kcal mol −1 and −13.3 ± 0.2 kcal mol −1 , respectively, which shows that the binding constant of aspterric acid to the active site is about 6,000 times greater than α,β-dihydroxyisovalerate. This further confirms that aspterric acid is a competitive inhibitor of AthDHAD. Cytotoxicity assay of aspterric acid. Cell proliferation experiments were performed in a 96-well format (five replicates per sample) using the human melanoma cell lines A375 and SK-MEL-1. Aspterric acid treatments were initiated 24 h after seeding for 72 h, and cell survival was quantified using the CellTiter-GLO assay (Promega). Cross experiment of A. thaliana. To make male sterile A. thaliana, aspterric acid was added to a chemical hybridization agent (CHA) formulation (250 μM aspterric acid, 2% ethanol, 0.1% Tween-80, 1% corn oil in water), which has less inhibition effect on the growth of A. thaliana. Flowers of the aspterric acid-treated Col-0 were selected as the female parent. The non-treated A. thaliana containing a glufosinate resistance gene were used as the male parent to donate pollen. Two-week-old F1 progeny resulting from the cross were treated by Finale (11.3% glufosinate-ammonium) at a 1:2,000 dilution. The results are summarized in Extended Data Fig. 9 . Construction of the transgenic plants. The coding sequence of AstD was codon optimized for A. thaliana. A chloroplast-localization signal (CLS) of 35 amino acid residues derived from the N-terminal of A. thaliana DHAD (MQATIFSPRATLFPCKPLLPSHNVNSRRPSIISCS) was fused to the N terminus of the codon-optimized AstD. A 3 × Flag-tag was inserted between the CLS and the codon-optimized AstD (Supplementary Table 6 ). The gene block containing CLS, the Flag-tag and astD was synthesized and then cloned into pEG202 vector using Gateway LR Clonase II Enzyme Mix (Thermo Fisher Scientific). The original CaMV 35S promoter of pEG202 was substituted by the ubiquitin-10 promoter to drive the expression of AstD. The construct was electro-transformed into Agrobacterium tumefaciens strain Agl0 and then transformed into A. thaliana using the standard floral dip method 49 . The A. thaliana Col-0 ecotype was transformed. Positive transgenic plants were selected using the glufosinate resistance marker, and were tested for survival in the presence of aspterric acid.
Letter reSeArCH
Extended Data Fig. 1 | The rationale of resistance-gene-directed discovery of a natural herbicide with a new mode of action. a, Phylogenetic tree of DHAD among bacteria, fungi and plants. The evolutionary history was inferred by using the neighbour-joining method (MEGA7). Scale-bar units represent the number of amino acid substitutions per site. b, Representatives of small molecules that inhibit DHAD in vitro, but fail to inhibit plant growth. c, Examples of co-localization of biosynthetic gene clusters (BGCs) and targets.
The biosynthetic core genes are shown in blue and the self-resistance enzymes (SREs) are shown in red. The blockbuster cholesterol-lowering lovastatin drug targets HMG-CoA reductase (HMGR) in eukaryotes. In the fungus A. terreus that produces lovastatin, a second copy of HMGR encoded by ORF8 is present in the gene cluster (top). The BGC of the immunosuppressant mycophenolic acid from Penicillium sp. contains a second copy of inosine monophosphate dehydrogenase (IMPDH), which represents the SRE to this cluster (bottom). A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
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Data collection
Diffraction data of holo-pDHAD was indexed, integrated, and scaled using the HKL3000 package.
Data analysis
The phylogenetic analysis was done by using MEGA (Molecular Evolutionary Genetics Analysis) version 7.
The holo-pDHAD structure was solved by the molecular replacement method Phaser embedded in the CCP4i suite, the resulting model were refined against the diffraction data using the REFMAC5 program of CCP4i.
The side chains of holo-pDHAD protein, iron sulfur cluster, water molecule, acetate ion, sulfate ions, and magnesium ion were manually built using the program WinCoot. The geometry of the model was validated by WinCoot.
Homology modeling of AstD and docking of substrates to holo-pDHAD was performed using Schrodinger suite software and Glide respectively.
Hydrogen atoms were added to crystal structures with the PROPKA tool in Protein Preparation tool in Maestro to optimize the hydrogen bond network. The MM/GBSA calculations had been done in Prime (Schrödinger 2015 suite). Protein−ligand van der Waals contacts, electrostatic interactions, ligand desolvation, and internal strain energies, using VSGB2.0 implicit solvent model with the OPLS2005 force field.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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All the data supporting this report is available in maintext and supplementary information.
Field-specific reporting
Please select the best fit for your research. If you are not sure, read the appropriate sections before making your selection.
Life sciences Behavioural & social sciences
For a reference copy of the document with all sections, see nature.com/authors/policies/ReportingSummary-flat.pdf
Life sciences
Study design
All studies must disclose on these points even when the disclosure is negative.
Sample size
The sample size of Arabidopsis plants was determined based on two factors 1. sufficient amount of plants are included to determine the consistence ; 2. Individual plants are properly spaced to allowed accurate measuring of their phenotype. Our Arabidopsis sample size (n) is always bigger than 10. The phenotype of plants that are growing on media is highly consistent, with minimal variation.
Data exclusions no data was excluded.
Replication
Multiple transgenic plants were examined. The experiments were repeated on different days. We also tested different generations of the transgenic plants, to make sure the phenotype is consistent and stable. All attempts at replication were successful.
Randomization Plants of different genetic backgrounds were randomly positioned to mitigate potential variables, which include the availability of water, light and air flow.
Blinding
Data collection, such as the measurements of weight and height were conducted by a third person who was blinded to sample identities.
Materials & experimental systems
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